Publications

We kindly request for authors who use STTARR resources to include the following acknowledgement in their publication:
“The authors would like to acknowledge the Spatio-Temporal Targeting and Amplification of Radiation Response (STTARR) program and its affiliated funding agencies.”

Select a year to see a listing of articles published.

  1. Wang, C. R., Mahmood, J., Zhang, Q. R., Vedadi, A., Warrington, J., Ou, N., … & Lu, Q. B. (2016). In Vitro and In Vivo Studies of a New Class of Anticancer Molecules for Targeted Radiotherapy of Cancer. Molecular Cancer Therapeutics, molcanther-0862.
  2. Au, B. C., Lee, C. J., Lopez-Perez, O., Foltz, W., Felizardo, T. C., Wang, J., … & Jaffray, D. A. (2016). Direct Lymph Node Vaccination of Lentivector/Prostate-Specific Antigen is Safe and Generates Tissue-Specific Responses in Rhesus Macaques. Biomedicines, 4(1), 6.
  3. Tata, A., Gribble, A., Ventura, M., Ganguly, M., Bluemke, E., Ginsberg, H. J., … & Zarrine-Afsar, A. (2016). Wide-field tissue polarimetry allows efficient localized mass spectrometry imaging of biological tissues. Chemical Science.
  4. Juneja, S. C., Viswanathan, S., Ganguly, M., & Veillette, C. (2016). A Simplified Method for the Aspiration of Bone Marrow from Patients Undergoing Hip and Knee Joint Replacement for Isolating Mesenchymal Stem Cells and In Vitro Chondrogenesis. Bone Marrow Research, 2016.
  5. Kim, S. M., Haider, M. A., Jaffray, D. A., & Yeung, I. W. (2016). Improved accuracy of quantitative parameter estimates in dynamic contrast-enhanced CT study with low temporal resolution. Medical physics, 43(1), 388-400.
  6. Dal Pra, A., Locke, J. A., Borst, G., Supiot, S., & Bristow, R. G. (2016). Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer. Frontiers in oncology, 6.
  7. Rodenhizer, Darren, et al. “A three-dimensional engineered tumour for spatial snapshot analysis of cell metabolism and phenotype in hypoxic gradients.”Nature materials 15.2 (2016): 227-234.
  8. Morrissy, A. Sorana, et al. “Divergent clonal selection dominates medulloblastoma at recurrence.” Nature 529.7586 (2016): 351-357.
  9. Edgar, L. J., Vellanki, R. N., McKee, T. D., Hedley, D., Wouters, B. G., & Nitz, M. (2016). Isotopologous Organotellurium Probes Reveal Dynamic Hypoxia In Vivo with Cellular Resolution. Angewandte Chemie, 128(42), 13353-13357.
  10. Bilkey, J., Tata, A., McKee, T. D., Porcari, A. M., Bluemke, E., Woolman, M., … & Zarrine-Afsar, A. (2016). Variations in the Abundance of Lipid Biomarker Ions in Mass Spectrometry Images Correlate to Tissue Density. Analytical Chemistry, 88(24), 12099-12107.
  11. Moonen, G., Satkunendrarajah, K., Wilcox, J. T., Badner, A., Mothe, A., Foltz, W., … & Tator, C. H. (2016). A New Acute Impact-Compression Lumbar Spinal Cord Injury Model in the Rodent. Journal of neurotrauma, 33(3), 278-289.
  12. Stapleton, S., Mirmilshteyn, D., Zheng, J., Allen, C., & Jaffray, D. A. (2016). Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors. JoVE (Journal of Visualized Experiments), (114), e54226-e54226.
  13. Hammoud, L., Adams, J. R., Loch, A. J., Marcellus, R. C., Uehling, D. E., Aman, A., … & Egan, S. E. (2016). Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation Assay. Stem cell reports, 7(4), 787-801.
  14. Her, S., Cui, L., Bristow, R. G., & Allen, C. (2016). Dual Action Enhancement of Gold Nanoparticle Radiosensitization by Pentamidine in Triple Negative Breast Cancer. Radiation research, 185(5), 549-562.
  15. Kostron, H., & Hasan, T. (Eds.). (2016). Photodynamic Medicine: From Bench to Clinic (Vol. 15). Royal Society of Chemistry.
  16. Sauvé, M., Hui, S. K., Dinh, D. D., Foltz, W. D., Momen, A., Nedospasov, S. A., … & Bolz, S. S. (2016). Tumor necrosis factor/sphingosine-1-phosphate signaling augments resistance artery myogenic tone in diabetes. Diabetes, db151450.
  17. Roberts, C. M., Shahin, S. A., Wen, W., Finlay, J. B., Dong, J., Wang, R., … & Glackin, C. A. (2016). Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models. Nanomedicine: Nanotechnology, Biology and Medicine.
  18. Sun, Y., & Chakrabartty, A. (2016). Cost-effective elimination of lipofuscin fluorescence from formalin-fixed brain tissue by white phosphor light emitting diode array. Biochemistry and Cell Biology, 94(6), 545-550.
  19. May, J. P., Hysi, E., Wirtzfeld, L. A., Undzys, E., Li, S. D., & Kolios, M. C. (2016). Photoacoustic Imaging of Cancer Treatment Response: Early Detection of Therapeutic Effect from Thermosensitive Liposomes. PLoS One, 11(10), e0165345.
  20. Yao, W., Xu, Y., Wang, W., & Kanopolous, P. (2016). Dependence of Dynamic Tensile Strength of Longyou Sandstone on Heat-Treatment Temperature and Loading Rate. Rock Mechanics and Rock Engineering, 49(10), 3899-3915.
  21. Patel, P., Kato, T., Ujiie, H., Wada, H., Lee, D., Hu, H. P., … & Yasufuku, K. (2016). Multi-Modal Imaging in a Mouse Model of Orthotopic Lung Cancer. PloS one, 11(9), e0161991.
  22. Muhanna, N., Cui, L., Chan, H., Burgess, L., Jin, C. S., MacDonald, T. D., … & Zheng, G. (2016). Multimodal Image-Guided Surgical and Photodynamic Interventions in Head and Neck Cancer: From Primary Tumor to Metastatic Drainage. Clinical Cancer Research, 22(4), 961-970.
  23. Stammes, M. A., Maeda, A., Bu, J., Scollard, D. A., Kulbatski, I., Medeiros, P. J., … & Chan, A. B. (2016). The necrosis-avid small Molecule hQ4-DTPa as a Multimodal imaging agent for Monitoring radiation Therapy-induced Tumor cell Death. Frontiers in oncology, 6.
  24. Zhou, B., Wang, L., Zhang, S., Bennett, B. D., He, F., Zhang, Y., … & Fargo, D. C. (2016). INO80 governs superenhancer-mediated oncogenic transcription and tumor growth in melanoma. Genes & development, 30(12), 1440-1453.
  25. Prodger, J. L., Gray, R. H., Shannon, B., Shahabi, K., Kong, X., Grabowski, K., … & Reynolds, S. J. (2016). Chemokine Levels in the Penile Coronal Sulcus Correlate with HIV-1 Acquisition and Are Reduced by Male Circumcision in Rakai, Uganda. PLoS Pathogens, 12(11), e1006025.
  26. Rodenhizer, D., Cojocari, D., Wouters, B. G., & McGuigan, A. P. (2016). Development of TRACER: tissue roll for analysis of cellular environment and response. Biofabrication, 8(4), 045008.
  27. Lam, K., Chan, C., & Reilly, R. M. (2016, December). Development and preclinical studies of 64Cu-NOTA-pertuzumab F (ab′) 2 for imaging changes in tumor HER2 expression associated with response to trastuzumab by PET/CT. In mAbs (pp. 1-11). Taylor & Francis.
  28. Dou, Y. N., Dunne, M., Huang, H., Mckee, T., Chang, M. C., Jaffray, D. A., & Allen, C. (2016). Thermosensitive liposomal cisplatin in combination with local hyperthermia results in tumor growth delay and changes in tumor microenvironment in xenograft models of lung carcinoma. Journal of Drug Targeting, 24(9), 865-877.
  29. Matsumoto, Y., La Rose, J., Kent, O. A., Wagner, M. J., Narimatsu, M., Levy, A. D., … & Storozhuk, Y. (2016). Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2. The Journal of Clinical Investigation, 126(12), 4482-4496.
  30. Ekdawi, S. N., Jaffray, D. A., & Allen, C. (2016). Nanomedicine and tumor heterogeneity: Concept and complex reality. Nano Today, 11(4), 402-414.

  1. Finlay, J., Roberts, C. M., Dong, J., Zink, J. I., Tamanoi, F., & Glackin, C. A. (2015). Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden. Nanomedicine: Nanotechnology, Biology and Medicine, 11(7), 1657-1666.
  2. Her, S., Jaffray, D. A., & Allen, C. (2015). Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements. Advanced drug delivery reviews.
  3. Chen, Y., Di Grappa, M. A., Molyneux, S. D., McKee, T. D., Waterhouse, P., Penninger, J. M., & Khokha, R. (2015). RANKL blockade prevents and treats aggressive osteosarcomas. Science translational medicine, 7(317), 317ra197-317ra197.
  4. Moonen, G., Satkunendrarajah, K., Wilcox, J. T., Badner, A., Mothe, A., Foltz, W., … & Tator, C. H. (2015). A New Acute Impact-Compression Lumbar Spinal Cord Injury Model in the Rodent. Journal of neurotrauma.
  5. Abbasi, A. Z., Prasad, P., Cai, P., He, C., Foltz, W. D., Amini, M. A., … & Wu, X. Y. (2015). Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer. Journal of Controlled Release, 209, 186-196.
  6. Ernsting, M. J., Hoang, B., Lohse, I., Undzys, E., Cao, P., Do, T., … & Li, S. D. (2015). Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle. Journal of Controlled Release, 206, 122-130.
  7. Lee, H., Zheng, J., Gaddy, D., Orcutt, K. D., Leonard, S., Geretti, E., … & Wickham, T. (2015). A gradient-loadable 64 Cu-chelator for quantifying tumor deposition kinetics of nanoliposomal therapeutics by positron emission tomography. Nanomedicine: Nanotechnology, Biology and Medicine, 11(1), 155-165.
  8. Yagi, K., Lidington, D., Wan, H., Fares, J. C., Meissner, A., Sumiyoshi, M., … & Nagahiro, S. (2015). Therapeutically Targeting Tumor Necrosis Factor-α/Sphingosine-1-Phosphate Signaling Corrects Myogenic Reactivity in Subarachnoid Hemorrhage. Stroke, 46(8), 2260-2270.
  9. Geretti, E., Leonard, S. C., Dumont, N., Lee, H., Zheng, J., De Souza, R., … & Nielsen, U. B. (2015). Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302). Molecular cancer therapeutics, 14(9), 2060-2071.
  10. Lam, K., Scollard, D. A., Chan, C., Levine, M. N., & Reilly, R. M. (2015). Kit for the preparation of 111 In-labeled pertuzumab injection for imaging response of HER2-positive breast cancer to trastuzumab (Herceptin).Applied Radiation and Isotopes, 95, 135-142.
  11. Karadimas, S., Laliberte, A., Tetreault, L., Chung, Y. S., Foltz, W. D., Arnold, P. M., & Fehlings, M. G. (2015). Riluzole Attenuates the Decompression-Induced Ischemia Reperfusion Injury and Enhances the Beneficial Impact of Decompression in Cervical Spondylotic Myelopathy.The Spine Journal, 15(10), S158-S159.
  12. Shiah, Y. J., Tharmapalan, P., Casey, A. E., Joshi, P. A., McKee, T. D., Jackson, H. W., … & Waterhouse, P. D. (2015). A progesterone-CXCR4 axis controls mammary progenitor cell fate in the adult gland. Stem cell reports,4(3), 313-322.
  13. Stares, E. (2015). Novel Magnetic Materials Based on Macrocyclic Ligands: Towards High Relaxivity Contrast Agents and Mononuclear Single-Molecule Magnets.
  14. Martinez, L., Ermolova, N. V., Ishikawa, T. O., Stout, D. B., Herschman, H. R., & Spencer, M. J. (2015). A reporter mouse for optical imaging of inflammation in mdx muscles. Skeletal muscle, 5(1), 1.
  15. Kubant, R., Poon, A. N., Sánchez-Hernández, D., Domenichiello, A. F., Huot, P. S. P., Pannia, E., … & Anderson, G. H. (2015). A comparison of effects of lard and hydrogenated vegetable shortening on the development of high-fat diet-induced obesity in rats. Nutrition & Diabetes, 5(12), e188.
  16. Stapleton, S., Milosevic, M., Tannock, I. F., Allen, C., & Jaffray, D. A. (2015). The intra-tumoral relationship between microcirculation, interstitial fluid pressure and liposome accumulation. Journal of Controlled Release,211, 163-170.
  17. Finlay, J., Roberts, C. M., Lowe, G., Loeza, J., Rossi, J. J., & Glackin, C. A. (2015). RNA-based TWIST1 inhibition via dendrimer complex to reduce breast cancer cell metastasis. BioMed research international, 2015.
  18. Huang, S., & Xia, K. (2015). Effect of heat-treatment on the dynamic compressive strength of Longyou sandstone. Engineering Geology, 191, 1-7.
  19. Karadimas, S. K., Laliberte, A. M., Tetreault, L., Chung, Y. S., Arnold, P., Foltz, W. D., & Fehlings, M. G. (2015). Riluzole blocks perioperative ischemia-reperfusion injury and enhances postdecompression outcomes in cervical spondylotic myelopathy. Science translational medicine, 7(316), 316ra194-316ra194.
  20. Hysi, E., May, J. P., Wirtzfeld, L., Undzys, E., Li, S. D., & Kolios, M. C. (2015, March). Probing the in vivo changes in oxygen saturation with photoacoustic imaging as a non-invasive means of assessing treatment progression. In SPIE BiOS (pp. 93231Z-93231Z). International Society for Optics and Photonics.
  21. Brink, K. S., Maddin, H. C., Evans, D. C., & Reisz, R. R. (2015). Re-evaluation of the historic Canadian fossil Bathygnathus borealis from the Early Permian of Prince Edward Island. Canadian Journal of Earth Sciences,52(12), 1109-1120.
  22. Muhanna, N., MacDonald, T. D., Chan, H., Jin, C. S., Burgess, L., Cui, L., … & Zheng, G. (2015). Multimodal Nanoparticle for Primary Tumor Delineation and Lymphatic Metastasis Mapping in a Head‐and‐Neck Cancer Rabbit Model. Advanced healthcare materials, 4(14), 2164-2169.
  23. Gladwish, A. P., Han, K., & Foltz, W. D. (2015). Variation in apparent diffusion coefficient measurements among women with locally advanced cervical cancer. Radiotherapy and Oncology, 117(3), 532-535.
  24. Velauthapillai, N. (2015). Oral Antioxidants for Radioprotection during Medical Imaging Examinations (Doctoral dissertation).
  25. Foltz, W. D., Porter, D. A., Simeonov, A., Aleong, A., Jaffray, D., Chung, P., … & Ménard, C. (2015). Readout-segmented echo-planar diffusion-weighted imaging improves geometric performance for image-guided radiation therapy of pelvic tumors. Radiotherapy and Oncology, 117(3), 525-531.
  26. Gani, C., Coackley, C., Kumareswaran, R., Schütze, C., Krause, M., Zafarana, G., & Bristow, R. G. (2015). In vivo studies of the PARP inhibitor, AZD-2281, in combination with fractionated radiotherapy: An exploration of the therapeutic ratio. Radiotherapy and Oncology, 116(3), 486-494.
  27. Frezza, C., Wouters, B. G., & McGuigan, A. P. (2015). A three-dimensional engineered tumour for spatial snapshot analysis of cell metabolism and phenotype in hypoxic gradients.
  28. Boyle, A. J., Cao, P. J., Hedley, D. W., Sidhu, S. S., Winnik, M. A., & Reilly, R. M. (2015). MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using 64 Cu-NOTA-panitumumab F (ab’) 2 fragments. Nuclear medicine and biology, 42(2), 71-77.
  29. Prodger, J. L., Ssemaganda, A., Ssetaala, A., Kitandwe, P. K., Muyanja, E., Mpendo, J., … & Kaul, R. (2015). Schistosoma mansoni Infection in Ugandan Men Is Associated with Increased Abundance and Function of HIV Target Cells in Blood, but Not the Foreskin: A Cross-sectional Study. PLoS Negl Trop Dis, 9(9), e0004067.
  30. Revelo, X. S., Tsai, S., Lei, H., Luck, H., Ghazarian, M., Tsui, H., … & Mak, T. W. (2015). Perforin is a novel immune regulator of obesity-related insulin resistance. Diabetes, 64(1), 90-103.
  31. Dou, Y. N., Weersink, R. A., Foltz, W. D., Zheng, J., Chaudary, N., Jaffray, D. A., & Allen, C. (2015). Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance. JoVE (Journal of Visualized Experiments), (106), e53055-e53055.
  32. Chang, Y. J., Pownall, S., Jensen, T. E., Mouaaz, S., Foltz, W., Zhou, L., … & Bilan, P. J. (2015). The Rho-guanine nucleotide exchange factor PDZ-RhoGEF governs susceptibility to diet-induced obesity and type 2 diabetes. eLife, 4, e06011
  33. Jaffray, D. A., Chung, C., Coolens, C., Foltz, W., Keller, H., Menard, C., … & Yeung, I. (2015, October). Quantitative imaging in radiation oncology: An emerging science and clinical service. In Seminars in radiation oncology (Vol. 25, No. 4, pp. 292-304). WB Saunders.
  1. Yeung, I., McKee, T., Jaffray, D., & Hill, R. (2014). STTARR: a radiation treatment and multi-modal imaging facility for fast tracking novel agent development in small animal models. In Proceedings of the international conference on radiation biology: frontiers in radiobiology-immunomodulation, countermeasures and therapeutics: abstract book, souvenir and scientific programme.
  2. Mikhail, A. S., Eetezadi, S., Ekdawi, S. N., Stewart, J., & Allen, C. (2014). Image-based analysis of the size-and time-dependent penetration of polymeric micelles in multicellular tumor spheroids and tumor xenografts.International journal of pharmaceutics, 464(1), 168-177.
  3. Han, S. M., Wan, H., Kudo, G., Foltz, W. D., Vines, D. C., Green, D. E., … & Ai, J. (2014). Molecular alterations in the hippocampus after experimental subarachnoid hemorrhage. Journal of Cerebral Blood Flow & Metabolism,34(1), 108-117.
  4. Montanari, S., Wang, X. H., Yannarelli, G., Dayan, V., Berger, T., Zocche, L., … & Keating, A. (2014). Development and characterization of a new inbred transgenic rat strain expressing DsRed monomeric fluorescent protein. Transgenic research, 23(5), 779-793.
  5. Cui, L., Tse, K., Zahedi, P., Harding, S. M., Zafarana, G., Jaffray, D. A., … & Allen, C. (2014). Hypoxia and Cellular Localization Influence the Radiosensitizing Effect of Gold Nanoparticles (AuNPs) in Breast Cancer Cells. Radiation research, 182(5), 475-488.
  6. Mahmood, J., Jelveh, S., Zaidi, A., Doctrow, S. R., Medhora, M., & Hill, R. P. (2014). Targeting the Renin–Angiotensin System Combined With an Antioxidant Is Highly Effective in Mitigating Radiation-Induced Lung Damage.International Journal of Radiation Oncology* Biology* Physics, 89(4), 722-728.
  7. Berlin, A., Lalonde, E., Zafarana, G., Sykes, J., Ramnarine, V. R., Lam, W., … & Bristow, R. G. (2014, February). Using NBN to predict biochemical relapse following image-guided radiotherapy (IGRT) for intermediate-risk prostate cancer (IR-PCa). In ASCO Annual Meeting Proceedings (Vol. 32, No. 4_suppl, p. 26).
  8. Zheng, J., De Souza, R., Jaffray, D., & Allen, C. (2014). Nanotechnology for Multimodality Imaging: Applications in Disease Detection and Treatment Guidance. In HANDBOOK OF NANOBIOMEDICAL RESEARCH: Fundamentals, Applications and Recent Developments: Volume 3. Applications in Diagnostics (pp. 145-193).
  9. Dhani, N. C., Lohse, I., Foltz, W. D., Cao, P. J., & Hedley, D. W. (2014). Estimating tumour volume in a primary orthotopic mouse model of human pancreatic cancer using rapid acquisition magnetic resonance imaging.
  10. Bartzsch, S. (2014). Microbeam Radiation Therapy–physical and biological aspects of a new cancer therapy and development of a treatment planning system.
  11. Moon, E. S., Karadimas, S. K., Yu, W. R., Austin, J. W., & Fehlings, M. G. (2014). Riluzole attenuates neuropathic pain and enhances functional recovery in a rodent model of cervical spondylotic myelopathy. Neurobiology of disease, 62, 394-406.
  12. Dou, Y. N., Zheng, J., Foltz, W. D., Weersink, R., Chaudary, N., Jaffray, D. A., & Allen, C. (2014). Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice.Journal of Controlled Release, 178, 69-78.
  13. Forgione, N., Karadimas, S. K., Foltz, W. D., Satkunendrarajah, K., Lip, A., & Fehlings, M. G. (2014). Bilateral contusion-compression model of incomplete traumatic cervical spinal cord injury. Journal of neurotrauma,31(21), 1776-1788.
  14. Yang, C., Neshatian, M., van Prooijen, M., & Chithrani, D. B. (2014). Cancer nanotechnology: enhanced therapeutic response using peptide-modified gold nanoparticles. Journal of nanoscience and nanotechnology, 14(7), 4813-4819.
  15. Cheng, L., Chang, Y., Wu, Q., Lin, W., & Singh, C. (2014). Evaluating charging service reliability for plug-in EVs from the distribution network aspect. Sustainable Energy, IEEE Transactions on, 5(4), 1287-1296.
  16. Berlin, A., Lalonde, E., Sykes, J., Zafarana, G., Chu, K. C., Ramnarine, V. R., … & Jurisica, I. (2014). NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer.Oncotarget, 5(22), 11081-90.
  17. Maeda, A., Bu, J., Chen, J., Zheng, G., & DaCosta, R. S. (2014). Dual in vivo photoacoustic and fluorescence imaging of HER2 expression in breast tumors for diagnosis, margin assessment, and surgical guidance. Mol Imaging, 13, 1-9.
  18. Jalali, S., Chung, C., Foltz, W., Burrell, K., Singh, S., Hill, R., & Zadeh, G. (2014). MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy. Neuro-oncology, 16(6), 868-879.
  19. Zhukova, N., Ramaswamy, V., Remke, M., Martin, D. C., Castelo-Branco, P., Zhang, C. H., … & Baskin, B. (2014). WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma. Acta neuropathologica communications, 2(1), 1.
  20. Govind, S. K., Zia, A., Hennings-Yeomans, P. H., Watson, J. D., Fraser, M., Anghel, C., … & Bristow, R. G. (2014). ShatterProof: operational detection and quantification of chromothripsis. BMC bioinformatics, 15(1), 1.
  21. Burrell, K., Singh, S., Jalali, S., Hill, R. P., & Zadeh, G. (2014). VEGF Regulates Region-Specific Localization of Perivascular Bone Marrow–Derived Cells in Glioblastoma. Cancer research, 74(14), 3727-3739.
  22. Prodger, J. L., Hirbod, T., Kigozi, G., Nalugoda, F., Reynolds, S. J., Galiwango, R., … & Kaul, R. (2014). Immune correlates of HIV exposure without infection in foreskins of men from Rakai, Uganda. Mucosal immunology, 7(3), 634-644.
  23. Li, J., Cai, P., Shalviri, A., Henderson, J. T., He, C., Foltz, W. D., … & Rauth, A. M. (2014). A multifunctional polymeric nanotheranostic system delivers doxorubicin and imaging agents across the blood–brain barrier targeting brain metastases of breast cancer. ACS nano, 8(10), 9925-9940.
  24. Agnihotri, S., Burrell, K., Buczkowicz, P., Remke, M., Golbourn, B., Chornenkyy, Y., … & Pajovic, S. (2014). ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents.Cancer discovery, 4(10), 1198-1213.
  25. Prodger, J. L. (2014). Defining Immune Correlates of HIV Susceptibility in the Foreskin (Doctoral dissertation).
  26. Moonen, G. (2014). Development and Characterization of an Acute Impact-Compression Lumbar Spinal Cord Injury Model in the Rat (Doctoral dissertation).
  27. Malik, F. (2014). The Modulation of the Cystic Fibrosis Transmembrane Conductance Regulator Protein by Sphingosine-1-Phosphate in the Cerebral Microvascular System (Doctoral dissertation).

  1. Stapleton, S., Milosevic, M., Allen, C., Zheng, J., Dunne, M., Yeung, I., & Jaffray, D. A. (2013). A mathematical model of the enhanced permeability and retention effect for liposome transport in solid tumors. PloS one, 8(12), e81157.
  2. Bae, Y. H., Mrsny, R. J., & Park, K. (2013). Cancer Targeted Drug Delivery. Springer New York.
  3. Ekdawi, S. N., Mikhail, A. S., Stapleton, S., Zheng, J., Eetezadi, S., Jaffray, D. A., & Allen, C. (2013). Long circulation and tumor accumulation. InCancer Targeted Drug Delivery (pp. 543-571). Springer New York.
  4. Mikhail, A. S., Eetezadi, S., & Allen, C. (2013). Multicellular tumor spheroids for evaluation of cytotoxicity and tumor growth inhibitory effects of nanomedicines in vitro: a comparison of docetaxel-loaded block copolymer micelles and Taxotere®. PloS one, 8(4), e62630.
  5. Chang, Q., Foltz, W. D., Chaudary, N., Hill, R. P., & Hedley, D. W. (2013). Tumor–stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition. International Journal of Cancer, 133(1), 225-234.
  6. Shalviri, A., Foltz, W. D., Cai, P., Rauth, A. M., & Wu, X. Y. (2013). Multifunctional terpolymeric MRI contrast agent with superior signal enhancement in blood and tumor. Journal of Controlled Release, 167(1), 11-20.
  7. Cui, L., Zahedi, P., Saraceno, J., Bristow, R., Jaffray, D., & Allen, C. (2013). Neoplastic cell response to tiopronin-coated gold nanoparticles.Nanomedicine: Nanotechnology, Biology and Medicine, 9(2), 264-273.
  8. Klinz, S. G., Zheng, J., De Souza, R., Dunne, M., Cain, J., Kim, J., … & Fitzgerald, J. (2013). Abstract C293: Irinotecan sucrosofate liposome injection, MM-398, demonstrates superior activity and control of hypoxia as measured through longitudinal imaging using [18F] FAZA PET compared to free irinotecan in a colon adenocarcinoma xenograft model. Molecular Cancer Therapeutics, 12(11 Supplement), C293-C293.
  9. Chattopadhyay, N., Cai, Z., Kwon, Y. L., Lechtman, E., Pignol, J. P., & Reilly, R. M. (2013). Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation. Breast cancer research and treatment, 137(1), 81-91.
  10. Lohse, I., Cao, P., Do, T., Ibrahimov, E., Tsao, M. S., & Hedley, D. W. (2013). Abstract B282: The PLK-4 inhibitor CFI-400945 reduces tumor growth in patient-derived pancreatic xenografts. Molecular Cancer Therapeutics,12(11 Supplement), B282-B282.
  11. Fraser, M. E., de Borja, R., Trudel, D., Harding, N. J., Hennings-Yeomans, P. H., Meng, A., … & Zia, A. (2013). A molecular portrait of potentially curable prostate cancer. Cancer Research, 73(8 Supplement), 2003-2003.
  12. Gordon, P. G. (2013). Thin Film Precursors, Properties and Applications: Chemical Vapour Deposition and Atomic Layer Deposition of Group 4, 11 and 13 Elements and Their Oxides (Doctoral dissertation, Carleton University Ottawa).
  13. Zannella, V. E., Dal Pra, A., Muaddi, H., McKee, T. D., Stapleton, S., Sykes, J., … & Wouters, B. G. (2013). Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response. Clinical Cancer Research, 19(24), 6741-6750.
  14. Murakami, M., Ernsting, M. J., Undzys, E., Holwell, N., Foltz, W. D., & Li, S. D. (2013). Docetaxel Conjugate Nanoparticles That Target α-Smooth Muscle Actin–Expressing Stromal Cells Suppress Breast Cancer Metastasis. Cancer research, 73(15), 4862-4871.
  15. Huang, H., Dunne, M., Lo, J., Jaffray, D. A., & Allen, C. (2013). Comparison of computed tomography-and optical image-based assessment of liposome distribution. Mol Imaging, 12(3), 148-160.
  16. Foomany, F. H., Beheshti, M., Magtibay, K., Masse, S., Foltz, W., Sevaptsidis, E., … & Umapathy, K. (2013, July). Analysis of reliability metrics and quality enhancement measures in current density imaging. InEngineering in Medicine and Biology Society (EMBC), 2013 35th Annual International Conference of the IEEE (pp. 4394-4397). IEEE.
  17. Stapleton, S., & Milosevic, M. F. (2013). Pressure gradients in solid tumors. In Cancer Targeted Drug Delivery (pp. 241-272). Springer New York.
  18. Ding, H., Helguera, G., Rodríguez, J. A., Markman, J., Luria-Pérez, R., Gangalum, P., … & Holler, E. (2013). Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer. Journal of Controlled Release, 171(3), 322-329.
  19. Hoang, B., Ekdawi, S. N., Reilly, R. M., & Allen, C. (2013). Active targeting of block copolymer micelles with trastuzumab fab fragments and nuclear localization signal leads to increased tumor uptake and nuclear localization in HER2-overexpressing xenografts. Molecular pharmaceutics, 10(11), 4229-4241.
  20. MacDonald, T. (2013). Metalloporphysomes: Engineering New Metalloporphyrin Nanoparticles (Doctoral dissertation).
  21. Holler, E., Penichet, M. L., & Ljubimova, J. Y. (2013). Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer.
  22. Chung, C., Jalali, S., Foltz, W., Burrell, K., Wildgoose, P., Lindsay, P., … & Zadeh, G. (2013). Imaging biomarker dynamics in an intracranial murine glioma study of radiation and antiangiogenic therapy. International Journal of Radiation Oncology* Biology* Physics, 85(3), 805-812.
  23. Karadimas, S. K., Moon, E. S., Yu, W. R., Satkunendrarajah, K., Kallitsis, J. K., Gatzounis, G., & Fehlings, M. G. (2013). A novel experimental model of cervical spondylotic myelopathy (CSM) to facilitate translational research.Neurobiology of disease, 54, 43-58.
  24. Dal Pra, A., Lalonde, E., Sykes, J., Warde, F., Ishkanian, A., Meng, A., … & van der Kwast, T. (2013). TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repair.Clinical Cancer Research, 19(18), 5202-5209.
  25. Eaker, S., Armant, M., Brandwein, H., Burger, S., Campbell, A., Carpenito, C., … & Van’t Hof, W. (2013). Concise review: guidance in developing commercializable autologous/patient-specific cell therapy manufacturing.Stem cells translational medicine, 2(11), 871-883.
  26. Burrell, K., Agnihotri, S., Leung, M., DaCosta, R., Hill, R., & Zadeh, G. (2013). A novel high-resolution in vivo imaging technique to study the dynamic response of intracranial structures to tumor growth and therapeutics. Journal of visualized experiments: JoVE, (76).
  27. Grant, J., Zahedi, P., Tsallas, A., & Allen, C. (2013). Thermosensitive Depot‐Forming Injectable Phosphatidylcholine Blends Tailored for Localized Drug Delivery. Journal of pharmaceutical sciences, 102(10), 3623-3631.
  28. Liu, T. W., MacDonald, T. D., Jin, C. S., Gold, J. M., Bristow, R. G., Wilson, B. C., & Zheng, G. (2013). Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases.ACS nano, 7(5), 4221-4232.
  29. McLean, D., Cooke, M. J., Albay III, R., Glabe, C., & Shoichet, M. S. (2013). Positron emission tomography imaging of fibrillar parenchymal and vascular amyloid-β in TgCRND8 mice. ACS chemical neuroscience, 4(4), 613-623.
  30. Shuhendler, A. J., Prasad, P., Cai, P., Hui, K. K., Henderson, J. T., Rauth, A. M., & Wu, X. Y. (2013). Matrigel alters the pathophysiology of orthotopic human breast adenocarcinoma xenografts with implications for nanomedicine evaluation. Nanomedicine: Nanotechnology, Biology and Medicine, 9(6), 795-805.
  31. Kim, S. M., Haider, M. A., Milosevic, M., & Yeung, I. W. (2013). A comparison of dynamic contrast‐enhanced CT and MR imaging‐derived measurements in patients with cervical cancer. Clinical physiology and functional imaging, 33(2), 150-161.
  32. McLean, D. (2013). Antibody-mediated Positron Emission Tomography Imaging of Brain Amyloid-β Pathology (Doctoral dissertation, University of Toronto).
  33. Orava, E. W. (2013). Functional DNA Aptamers as Biotherapeutic Molecules(Doctoral dissertation, University of Toronto).
  1. Maeda, A., Leung, M. K., Conroy, L., Chen, Y., Bu, J., Lindsay, P. E., … & Wang, Y. (2012). In vivo optical imaging of tumor and microvascular response to ionizing radiation. PloS one, 7(8), e42133.
  2. Shao, W., Yu, Z., Chiang, Y., Yang, Y., Chai, T., Foltz, W., … & Jin, T. (2012). Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PloS one, 7(1), e28784.
  3. Ernsting, M. J., Foltz, W. D., Undzys, E., Tagami, T., & Li, S. D. (2012). Tumor-targeted drug delivery using MR-contrasted docetaxel–carboxymethylcellulose nanoparticles. Biomaterials, 33(15), 3931-3941.
  4. Hoang, B., Reilly, R. M., & Allen, C. (2012). Block copolymer micelles target auger electron radiotherapy to the nucleus of HER2-positive breast cancer cells. Biomacromolecules, 13(2), 455-465.
  5. Fonge, H., Huang, H., Scollard, D., Reilly, R. M., & Allen, C. (2012). Influence of formulation variables on the biodistribution of multifunctional block copolymer micelles. Journal of controlled release, 157(3), 366-374.
  6. Mahmood, J., Jelveh, S., Zaidi, A., Doctrow, S. R., & Hill, R. P. (2012). Mitigation of radiation-induced lung injury with EUK-207 and genistein: effects in adolescent rats. Radiation research, 179(2), 125-134.
  7. McGrath, D. M., Foltz, W. D., Al‐Mayah, A., Niu, C. J., & Brock, K. K. (2012). Quasi‐static magnetic resonance elastography at 7 T to measure the effect of pathology before and after fixation on tissue biomechanical properties. Magnetic resonance in medicine, 68(1), 152-165.
  8. Zaidi, A., Jelveh, S., Mahmood, J., & Hill, R. P. (2012). Effects of lipopolysaccharide on the response of C57BL/6J mice to whole thorax irradiation. Radiotherapy and Oncology, 105(3), 341-349.
  9. Mckee, T. D., Chen, J., Corbin, I., Zheng, G., & Khokha, R. (2012). Quantifying nanoparticle transport in vivo using hyperspectral imaging with a dorsal skinfold window chamber. Journal of Innovative Optical Health Sciences, 5(04), 1250023.
  10. Sun, J., Maeda, A., Stapleton, S., Chen, Y., Heinmiller, A., Bate, D., … & DaCosta, R. (2012). Monitoring radiation response in tumor vasculature using intravital photoacoustic imaging in a murine window chamber model in vivo.Cancer Research, 72(8 Supplement), 4338-4338.
  11. Huang, H. (2012). Comparison of CT and Optical Image-based Assessment of Liposome Distribution (Doctoral dissertation, University of Toronto).
  12. Lee, H., Zheng, J., Gaddy, D., Kirpotin, D., Dunne, M., Drummond, D., … & Wickham, T. (2012). A Novel 64Cu-Liposome PET Agent (MM-DX-929) Predicts Response to Liposomal Chemotherapeutics in Preclinical Breast Cancer Models.
  13. Leckie, A. E., Akens, M. K., Woodhouse, K. A., Yee, A. J., & Whyne, C. M. (2012). Evaluation of thiol-modified hyaluronan and elastin-like polypeptide composite augmentation in early-stage disc degeneration: comparing 2 minimally invasive techniques. Spine, 37(20), E1296-E1303.
  14. Lee, J., Satkunendrarajah, K., & Fehlings, M. G. (2012). Development and characterization of a novel rat model of cervical spondylotic myelopathy: the impact of chronic cord compression on clinical, neuroanatomical, and neurophysiological outcomes. Journal of neurotrauma, 29(5), 1012-1027.
  15. Austin, J. W., Kang, C. E., Baumann, M. D., DiDiodato, L., Satkunendrarajah, K., Wilson, J. R., … & Fehlings, M. G. (2012). The effects of intrathecal injection of a hyaluronan-based hydrogel on inflammation, scarring and neurobehavioural outcomes in a rat model of severe spinal cord injury associated with arachnoiditis. Biomaterials, 33(18), 4555-4564.
  16. Foltz, W. D., & Jaffray, D. A. (2012). Principles of magnetic resonance imaging. Radiation research, 177(4), 331-348.
  17. McLean, D., Cooke, M. J., Wang, Y., Green, D., Fraser, P. E., St George-Hyslop, P., & Shoichet, M. S. (2012). Anti-Amyloid-β-Mediated Positron Emission Tomography Imaging in Alzheimer’s Disease Mouse Brains. PloS one, 7(12), e51958.
  18. Chattopadhyay, N. (2012). Development, Characterization and Validation of Trastuzumab-Modified Gold Nanoparticles for Molecularly Targeted Radiosensitization of Breast Cancer (Doctoral dissertation, University of Toronto).
  19. Zafarana, G., Ishkanian, A. S., Malloff, C. A., Locke, J. A., Sykes, J., Thoms, J., … & Meng, A. (2012). Copy number alterations of c‐MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy.Cancer, 118(16), 4053-4062.
  20. Fraser, M., Zhao, H., Luoto, K. R., Lundin, C., Coackley, C., Chan, N., … & Bristow, R. G. (2012). PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy. Clinical Cancer Research, 18(4), 1015-1027.
  21. Zannella, V. (2012). A Genetic and Pharmacological Response to Improve Radiation Response (Doctoral dissertation).
  22. Fraser, M., Zhao, H., Luoto, K. R., Lundin, C., Coackley, C., Chan, N., … & Bristow, R. G. (2012). Europe PMC Funders Group. Clin Cancer Res, 18(4), 1015-1027.
  23. Agnihotri, S., Gajadhar, A. S., Ternamian, C., Gorlia, T., Diefes, K. L., Mischel, P. S., … & Sarkaria, J. N. (2012). Alkylpurine–DNA–N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients. The Journal of clinical investigation, 122(1), 253-266.
  24. Cheung, M. C. (2012). A Ribosome-Inactivating Protein Toxin as a Template for Cancer Drug Discovery (Doctoral dissertation, University of Toronto).
  1. Jelveh S, Chithrani DB. Gold nanostructures as a platform for combinational therapy in future cancer therapeutics. Cancers 3(1):1081-1110. 2011
  2. Mahmood J, Jelveh S, Calveley V, Zaidi A, Doctrow SR, Hill RP. Mitigation of lung injury after accidental exposure to radiation. Radiat Res 176(6):770-80. Dec 2011.
  3. McGrath DM, Foltz WD, Al-Mayah A, Niu CJ, Brock KK. Quasi-static magnetic resonance elastography at 7 T to measure the effect of pathology before and after fixation on tissue biomechanical properties. Magn Reson Med 1522-2594. Dec 2011.
  4. Vines DC, Green DE, Kudo G, Keller H. Evaluation of Mouse Tail-vein Injections Both Qualitatively and Quantitatively on Small-Animal PET Tail Scans. J Nucl Med Technol 39(4):264-70. Dec 2011.
  5. Locke JA, Zafarana G, Malloff CA, Lam WL, Sykes J, Pintilie M, Ramnarine VR, Meng AX, Ahmed O., Jurisica I, Guns ET, van der Kwast T, Milosevic M, Bristow RG. Allelic Loss of the Loci Containing StAR is Prognostic for Relapse in Intermediate-Risk Prostate Cancer. The Prostate. Dec 2011.
  6. Fraser M, Zhao H, Luoto KR, Lundin C, Coackley CL, Chan N, Joshua AM, Bismar TA, Evans A, Helleday T, Bristow RG. PTEN Deletion in Prostate Cancer Cells Does Not Associate With Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy. Clin Cancer Res. Nov 2011.
  7. McLarty K, Moran MD, Scollard DA, Chan C, Sabha N, Mukherjee J, Guha A, McLaurin J, Nitz M, Houle S, Wilson AA, Reilly RM, Vasdev N. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice. Nucl Med Biol 38(7):953-9. Oct 2011.
  8. Al-Bahlani S, Fraser M, Wong AY, Sayan BS, Bergeron R, Melino G, Tsang BK. P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism. Oncogene 13;30(41):4219-30. Oct 2011.
  9. Zhao H, Luoto KR, Meng AX, Bristow RG. The receptor tyrosine kinase inhibitor amuvatinib (MP470) sensitizes tumor cells to radio- and chemo-therapies in part by inhibiting homologous recombination. Radiother Oncol 101(1):59-65. Oct 2011.
  10. Kim SM, Haider MA, Milosevic M, Jaffray DA, Yeung IW. A method for patient dose reduction in dynamic contrast enhanced CT study. Med Phys 38(9):5094-103. Sep 2011.
  11. Dunne M, Zheng J, Jaffray DA, Allen C. APN/CD13-Targeting as a Strategy to Alter the Tumor Accumulation of Liposomes. J Control Release 154(3):298-305. Sep 2011.
  12. Dunne M, Zheng J, Rosenblat J, Jaffray DA, Allen C. APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes. J Control Release 154(3):298-305. Sep 2011.
  13. Loai Y, Sakib N, Janik R, Foltz WD, Margaret Cheng HL. Human aortic endothelial cell labeling with positive contrast gadolinium oxide nanoparticles for cellular Magnetic Resonance Imaging at 7 Tesla. Mol Imaging. Sep 2011.
  14. Tagami T, Foltz WD, Ernsting MJ, Lee CM, Tannock IF, May JP, Li SD. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome. Biomaterials 32(27):6570-8. Sep 2011.
  15. Al Rashid ST, Harding SM, Law C, Coackley C, Bristow RG. Protein-Protein Interactions Occur Between p53 Phosphoforms and ATM and 53BP1 at Sites of Exogenous DNA Damage. Radiation Research 175(5), 588-598. May 2011.
  16. Yu Z, Shao W, Chiang Y, Foltz W, Zhang Z, Ling W, Fantus IG, Jin T. Oltipraz upregulates the nuclear respiratory factor 2 alpha subunit (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice. Diabetologia 54(4):922-34. Apr 2011.
  17. Shuhendler AJ, Prasad P, Chan HK, Gordijo CR, Soroushian B, Kolios M, Yu K, O’Brien PJ, Rauth AM, Wu XY. Hybrid Quantum Dot−Fatty Ester Stealth Nanoparticles: Toward Clinically Relevant in Vivo Optical Imaging of Deep Tissue. ACS Nano 5 (3), 1958-1966. Mar 2011.
  18. Clarkson R, Lindsay PE, Ansell S, Wilson G, Jelveh S, Hill RP, Jaffray DA. Characterization of image quality and image-guidance performance of a preclinical microirradiator. Med Phys 38(2):845-56. Feb 2011.
  19. Thoms J, Goda JS, Zlotta AR, Fleshner NE, van der Kwast TH, Supiot S, Warde P, Bristow RG. Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer. Nat Rev Clin Oncol 8(2):107-13. Feb 2011.
  20. Chithrani DB. Optimization of Bio-Nano Interface Using Gold Nanostructures as a Model Nanoparticle System. Insciences J 1(3), 115-135. 2011.
  1. Chithrani DB. Nanoparticles for improved therapeutics and imaging in cancer therapy. Recent Pat Nanotechnol 4(3):171-80. Nov 2010.
  2. Lee H, Hoang B, Fonge H, Reilly RM, Allen C. In Vivo Distribution of Polymeric Nanoparticles at the Whole-Body, Tumor, and Cellular Levels. Pharm Res 27(11):2343-55. Nov 2010.
  3. Luoto KR, Meng AX, Wasylishen AR, Zhao H, Coackley CL, Penn LZ, Bristow RG. Therapeutics, Targets, and Chemical Biology: Tumor Cell Kill by c-MYC Depletion: Role of MYC-Regulated Genes that Control DNA Double-Strand Break Repair. Cancer Res70(21):8748-59. Nov 2010.
  4. Chalmers AJ, Lakshman M, Chan N, Bristow RG. Poly(ADP-Ribose) Polymerase Inhibition as a Model for Synthetic Lethality in Developing Radiation Oncology Targets. Semin Radiat Oncol 20(4):274-81. Oct 2010.
  5. Thoms J, Bristow RG. DNA Repair Targeting and Radiotherapy: A Focus on the Therapeutic Ratio. Semin Radiat Oncol 20(4):217-22. Oct 2010.
  6. Chithrani DB. Intracellular uptake, transport, and processing of gold nanostructures. Mol Membr Biol 27(7):299-311. Oct 2010.
  7. Ishkanian AS, Zafarana G, Thoms J, Bristow RG. Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer. Acta Oncol 49(7):888-94. Oct 2010.
  8. Lee H, Fonge H, Hoang B, Reilly RM, Allen C. The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Mol Pharm 7(4):1195-208. Aug 2010.
  9. Zafarana G, Bristow RG. Tumor senescence and radioresistant tumor-initiating cells (TICs): let sleeping dogs lie! Breast Cancer Res 5;12(4):111. Jul 2010.
  10. Chithrani DB, Jelveh S, Jalali F, van Prooijen M, Allen C, Bristow RG, Hill RP, Jaffray DA. Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat Res 173(6):719-28. Jun 2010.
  11. Mai S, Wei K, Flenniken A, Adamson SL, Rossant J, Aubin JE, Gong SG. The missense mutation W290R in Fgfr2 causes developmental defects from aberrant IIIb and IIIc signaling. Dev Dyn 239(6):1888-900. Jun 2010.
  12. Zheng J, Allen C, Serra S, Vines D, Charron M, Jaffray DA. Liposome Contrast Agent for CT-based Detection and Localization of Neoplastic and Inflammatory Lesions in Rabbits: Validation with FDG-PET and Histology. Contrast Media Mol Imaging 5(3):147-54. May-Jun 2010.
  13. Cheung MC, Revers L, Perampalam S, Wei X, Kiarash R, Green DE, Abdul-Wahid A, Gariépy J. An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo. Mol Cancer 3;9:28. Feb 2010.
  14. Fonge H, Lee H, Reilly RM, Allen C. Multifunctional block copolymer micelles for the delivery of 111in to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy. Mol Pharm 7(1):177-86. Feb 2010.
  15. Dunne, M. (2010). Quantitative In Vivo Assessment of Tumour Vasculature-Targeted Liposomes (Doctoral dissertation, University of Toronto).
  1. McLarty K, Fasih A, Scollard DA, Done SJ, Vines DC, Green DE, Costantini DL, Reilly RM. 18F-FDG small-animal PET/CT differentiates trastuzumab- responsive from unresponsive human breast cancer xenografts in athymic mice. J Nucl Med 50(11):1848-56. Nov 2009.
  2. S Kim SM, Haider MA, Milosevic M, Yeung IW. Interindividual variability of arterial impulse response to intravenous injection of nonionic contrast agent (Iohexol) in DCE-CT study. Med Phys 36(10):4791-802. Oct 2009.
  3. Vasdev N, Chio J, van Oosten EM, Nitz M, McLaurin J, Vines DC, Houle S, Reilly RM, Wilson AA. Synthesis and preliminary biological evaluations of [18F]-1- deoxy-1-fluoro-scyllo-inositol. Chem Commun (Camb) (37):5527-9. Oct 2009.
  4. Chopra S, Foltz WD, Milosevic MF, Toi A, Bristow RG, Ménard C, Haider MA. Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: A pilot study in men with prostate cancer. Int J Radiat Biol 85(9):805-13. Sep 2009.
  5. Bhogal N, Jalali F, Bristow RG. Microscopic imaging of DNA repair foci in irradiated normal tissues. Int J Radiat Biol 85(9):732-46. Sept 2009.
  6. De Paoli P. Institutional shared resources and translational cancer research. J Transl Med 7:54. Jun 2009.
  7. Chan N, Koch CJ, Bristow RG. Tumor hypoxia as a modifier of DNA strand break and cross-link repair. Curr Mol Med 9(4):401-10. May 2009.
  8. Storr T, Scott LE, Bowen ML, Green DE, Thompson KH, Schugar HJ, Orvig C. Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer’s therapy. Dalton Trans (16):3034-43. Apr 2009.
  9. Zafarana G, Avery SR, Avery K, Moore HD and Andrews PW. Specific knockdown of OCT4 in human embryonic stem cells by inducible shRNAi. Stem Cells 27(4):776-82. Apr 2009.
  10. Zheng J, Allen C, Jaffray DA. Quantitative CT Imaging of the Spatial and Temporal Distribution of Liposomes in a Rabbit Tumor Model. Mol Pharm 6(2):571-80. Mar-Apr 2009.
  1. Lunt SJ, Fyles A, Hill RP, Milosevic M. Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis. Future Oncol 4(6):793-802. Dec 2008.
  2. Kim SM, Cho YB, Haider MA, Milosevic M, Yeung IW. Multiphasic contrast injection for improved precision of parameter estimates in functional CT. Med Phys 35(12):5921-33. Dec 2008.
  3. Liu SK, Coackley C, Krause M, Jalali F, Chan N, Bristow RG. A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia, Radiother Oncol 88(2):258-68. Aug 2008.
  4. Lunt SJ, Kalliomaki TM, Brown A, Yang VX, Milosevic M, Hill RP. Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours. BMC Cancer 8:2. Jan 2008.
  5. Zheng J, Jaffray DA, Allen C. Nanosystems for Multimodality in vivo Imaging. Book Title: Multifunctional Pharmaceutical Nanocarriers. Editor: Vladimir Torchilin. Publisher: Springer New York, 2008.
  6. Hoisak, J. D., Zheng, J., Allen, C., & Jaffray, D. A. (2008, March). Improved CT and MR image registration with the introduction of a dual-modality contrast agent: performance assessment using quantitative and information theoretic methods. In Medical Imaging (pp. 69140Z-69140Z). International Society for Optics and Photonics.
  1. Zheng J, Liu J, Dunne M, Jaffray DA, Allen C. In Vivo Performance of a Liposomal Vascular Contrast Agent for CT and MR-Based Image Guidance Applications. Pharm Res 24(6):1193-201. Jun 2007.